Global Pseudorabies Virus Vaccine Supply, Demand and Key Producers, 2026-2032
The global Pseudorabies Virus Vaccine market size is expected to reach $ 261 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Pseudorabies Virus Vaccine is a veterinary biological product used to protect pigs against pseudorabies virus infection, mainly covering piglets, fattening pigs, replacement gilts, sows and boars. It helps reduce clinical disease, mortality, reproductive losses and virus shedding in swine herds. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging materials. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global designed capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%–61%. Differentiated products such as marker vaccines, variant-strain inactivated vaccines and combination vaccines generally carry higher prices and margins than conventional live vaccines.
The current market for Pseudorabies Virus Vaccine is already a mature commercial segment within swine vaccines, with stable baseline immunization demand but clear regional differences. China and selected intensive swine-producing regions in Asia remain the most active demand centers, as large-scale farms continue to focus on reproductive stability, piglet survival, fattening herd health and farm-level purification programs. In parts of Europe and North America, disease eradication and monitoring systems are more mature, so commercial vaccine demand is relatively stable and mainly supported by a limited number of multinational animal health companies. Overall, this is not a high-growth emerging market, but a stable market driven by routine vaccination, product upgrading and higher-quality disease-control needs. Looking ahead, competition will gradually shift from the supply of conventional vaccines to comprehensive prevention solutions that better fit the immunization programs of large-scale swine farms. Integrated producers are paying more attention to strain matching, duration of protection, batch-to-batch consistency, safety and compatibility with other swine vaccines. This will encourage manufacturers to keep upgrading live vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines. Companies with stable manufacturing processes, strong strain reserves, field validation capabilities and farm-level technical service teams will be better positioned to enter the supplier systems of large farming groups. Future product value will come more from purification support, variant-strain control and improved overall immunization efficiency than from low-price competition alone. The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause meaningful production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually include it in their stable vaccination management systems. As producers raise their requirements for biosecurity, disease monitoring and production performance, the value of vaccine suppliers is no longer limited to the product itself. It also includes immunization program design, antibody monitoring support, purification-route advice and on-site technical services. Stricter regulation and higher quality requirements for veterinary biological products also favor suppliers with stronger technical capabilities and more complete quality systems. Key restraints include hog-cycle volatility, product homogenization, lower demand in some purified regions and the difficulty of proving clear product differentiation. When farm profitability is weak, small and medium-sized farms may reduce disease-prevention spending, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from channels and pricing. For new-generation marker vaccines, variant-strain inactivated vaccines and combination products, research, registration, field validation and scaled manufacturing all require long development cycles, so commercialization is not easy. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, strong access to integrated farming groups and solid technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
This report studies the global Pseudorabies Virus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pseudorabies Virus Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pseudorabies Virus Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pseudorabies Virus Vaccine total production and demand, 2021-2032, (K Dose)
Global Pseudorabies Virus Vaccine total production value, 2021-2032, (USD Million)
Global Pseudorabies Virus Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Pseudorabies Virus Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Pseudorabies Virus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pseudorabies Virus Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Pseudorabies Virus Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Pseudorabies Virus Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Pseudorabies Virus Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD Animal Health, Boehringer Ingelheim, HIPRA, Ceva Sant? Animale, Wuhan Keqian Biology, Pulike Biological Engineering, China Animal Husbandry Industry, Jinyu Bio-Technology, Guangdong Winsun Bio-Pharmaceutical, Huapai Biopharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pseudorabies Virus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pseudorabies Virus Vaccine Market, By Region:
1. How big is the global Pseudorabies Virus Vaccine market?
2. What is the demand of the global Pseudorabies Virus Vaccine market?
3. What is the year over year growth of the global Pseudorabies Virus Vaccine market?
4. What is the production and production value of the global Pseudorabies Virus Vaccine market?
5. Who are the key producers in the global Pseudorabies Virus Vaccine market?
6. What are the growth factors driving the market demand?
Pseudorabies Virus Vaccine is a veterinary biological product used to protect pigs against pseudorabies virus infection, mainly covering piglets, fattening pigs, replacement gilts, sows and boars. It helps reduce clinical disease, mortality, reproductive losses and virus shedding in swine herds. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging materials. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global designed capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%–61%. Differentiated products such as marker vaccines, variant-strain inactivated vaccines and combination vaccines generally carry higher prices and margins than conventional live vaccines.
The current market for Pseudorabies Virus Vaccine is already a mature commercial segment within swine vaccines, with stable baseline immunization demand but clear regional differences. China and selected intensive swine-producing regions in Asia remain the most active demand centers, as large-scale farms continue to focus on reproductive stability, piglet survival, fattening herd health and farm-level purification programs. In parts of Europe and North America, disease eradication and monitoring systems are more mature, so commercial vaccine demand is relatively stable and mainly supported by a limited number of multinational animal health companies. Overall, this is not a high-growth emerging market, but a stable market driven by routine vaccination, product upgrading and higher-quality disease-control needs. Looking ahead, competition will gradually shift from the supply of conventional vaccines to comprehensive prevention solutions that better fit the immunization programs of large-scale swine farms. Integrated producers are paying more attention to strain matching, duration of protection, batch-to-batch consistency, safety and compatibility with other swine vaccines. This will encourage manufacturers to keep upgrading live vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines. Companies with stable manufacturing processes, strong strain reserves, field validation capabilities and farm-level technical service teams will be better positioned to enter the supplier systems of large farming groups. Future product value will come more from purification support, variant-strain control and improved overall immunization efficiency than from low-price competition alone. The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause meaningful production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually include it in their stable vaccination management systems. As producers raise their requirements for biosecurity, disease monitoring and production performance, the value of vaccine suppliers is no longer limited to the product itself. It also includes immunization program design, antibody monitoring support, purification-route advice and on-site technical services. Stricter regulation and higher quality requirements for veterinary biological products also favor suppliers with stronger technical capabilities and more complete quality systems. Key restraints include hog-cycle volatility, product homogenization, lower demand in some purified regions and the difficulty of proving clear product differentiation. When farm profitability is weak, small and medium-sized farms may reduce disease-prevention spending, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from channels and pricing. For new-generation marker vaccines, variant-strain inactivated vaccines and combination products, research, registration, field validation and scaled manufacturing all require long development cycles, so commercialization is not easy. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, strong access to integrated farming groups and solid technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
This report studies the global Pseudorabies Virus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pseudorabies Virus Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pseudorabies Virus Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pseudorabies Virus Vaccine total production and demand, 2021-2032, (K Dose)
Global Pseudorabies Virus Vaccine total production value, 2021-2032, (USD Million)
Global Pseudorabies Virus Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Pseudorabies Virus Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Pseudorabies Virus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pseudorabies Virus Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Pseudorabies Virus Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Pseudorabies Virus Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Pseudorabies Virus Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD Animal Health, Boehringer Ingelheim, HIPRA, Ceva Sant? Animale, Wuhan Keqian Biology, Pulike Biological Engineering, China Animal Husbandry Industry, Jinyu Bio-Technology, Guangdong Winsun Bio-Pharmaceutical, Huapai Biopharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pseudorabies Virus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pseudorabies Virus Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Live Attenuated Vaccine
- Inactivated Vaccine
- Others
- Bartha-K61 Strain
- HB98 Strain
- C Strain
- Other
- Small Pack (Below 20 Doses per Vial)
- Medium Pack (20–50 Doses per Vial)
- Large Pack (Above 50 Doses per Vial)
- Large-scale Swine Farming Groups
- Breeding Farms
- Animal Disease Control Institutions
- Others
- MSD Animal Health
- Boehringer Ingelheim
- HIPRA
- Ceva Sant? Animale
- Wuhan Keqian Biology
- Pulike Biological Engineering
- China Animal Husbandry Industry
- Jinyu Bio-Technology
- Guangdong Winsun Bio-Pharmaceutical
- Huapai Biopharm
- Jilin Zhengye Biological Products
- Sinopharm Yangzhou VAC Biological Engineering
- Sinovet Animal Health
- Jofunhwa Group
- Harbin Weike Biotechnology
- Qilu Animal Health Products
- Harbin Pharmaceutical Group Bio-vaccine
- Qingdao Yebio Bioengineering
1. How big is the global Pseudorabies Virus Vaccine market?
2. What is the demand of the global Pseudorabies Virus Vaccine market?
3. What is the year over year growth of the global Pseudorabies Virus Vaccine market?
4. What is the production and production value of the global Pseudorabies Virus Vaccine market?
5. Who are the key producers in the global Pseudorabies Virus Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pseudorabies Virus Vaccine Introduction
1.2 World Pseudorabies Virus Vaccine Supply & Forecast
1.2.1 World Pseudorabies Virus Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Pseudorabies Virus Vaccine Production (2021-2032)
1.2.3 World Pseudorabies Virus Vaccine Pricing Trends (2021-2032)
1.3 World Pseudorabies Virus Vaccine Production by Region (Based on Production Site)
1.3.1 World Pseudorabies Virus Vaccine Production Value by Region (2021-2032)
1.3.2 World Pseudorabies Virus Vaccine Production by Region (2021-2032)
1.3.3 World Pseudorabies Virus Vaccine Average Price by Region (2021-2032)
1.3.4 North America Pseudorabies Virus Vaccine Production (2021-2032)
1.3.5 Europe Pseudorabies Virus Vaccine Production (2021-2032)
1.3.6 China Pseudorabies Virus Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pseudorabies Virus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pseudorabies Virus Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Pseudorabies Virus Vaccine Demand (2021-2032)
2.2 World Pseudorabies Virus Vaccine Consumption by Region
2.2.1 World Pseudorabies Virus Vaccine Consumption by Region (2021-2026)
2.2.2 World Pseudorabies Virus Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Pseudorabies Virus Vaccine Consumption (2021-2032)
2.4 China Pseudorabies Virus Vaccine Consumption (2021-2032)
2.5 Europe Pseudorabies Virus Vaccine Consumption (2021-2032)
2.6 Japan Pseudorabies Virus Vaccine Consumption (2021-2032)
2.7 South Korea Pseudorabies Virus Vaccine Consumption (2021-2032)
2.8 ASEAN Pseudorabies Virus Vaccine Consumption (2021-2032)
2.9 India Pseudorabies Virus Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pseudorabies Virus Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Pseudorabies Virus Vaccine Production by Manufacturer (2021-2026)
3.3 World Pseudorabies Virus Vaccine Average Price by Manufacturer (2021-2026)
3.4 Pseudorabies Virus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pseudorabies Virus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pseudorabies Virus Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Pseudorabies Virus Vaccine in 2025
3.6 Pseudorabies Virus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pseudorabies Virus Vaccine Market: Region Footprint
3.6.2 Pseudorabies Virus Vaccine Market: Company Product Type Footprint
3.6.3 Pseudorabies Virus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pseudorabies Virus Vaccine Production Value Comparison
4.1.1 United States VS China: Pseudorabies Virus Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pseudorabies Virus Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pseudorabies Virus Vaccine Production Comparison
4.2.1 United States VS China: Pseudorabies Virus Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pseudorabies Virus Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pseudorabies Virus Vaccine Consumption Comparison
4.3.1 United States VS China: Pseudorabies Virus Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pseudorabies Virus Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pseudorabies Virus Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
4.5 China Based Pseudorabies Virus Vaccine Manufacturers and Market Share
4.5.1 China Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
4.6 Rest of World Based Pseudorabies Virus Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pseudorabies Virus Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Live Attenuated Vaccine
5.2.2 Inactivated Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pseudorabies Virus Vaccine Production by Type (2021-2032)
5.3.2 World Pseudorabies Virus Vaccine Production Value by Type (2021-2032)
5.3.3 World Pseudorabies Virus Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY STRAIN PLATFORM
6.1 World Pseudorabies Virus Vaccine Market Size Overview by Strain Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Strain Platform
6.2.1 Bartha-K61 Strain
6.2.2 HB98 Strain
6.2.3 C Strain
6.2.4 Other
6.3 Market Segment by Strain Platform
6.3.1 World Pseudorabies Virus Vaccine Production by Strain Platform (2021-2032)
6.3.2 World Pseudorabies Virus Vaccine Production Value by Strain Platform (2021-2032)
6.3.3 World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Pseudorabies Virus Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Pseudorabies Virus Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pseudorabies Virus Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Swine Farming Groups
8.2.2 Breeding Farms
8.2.3 Animal Disease Control Institutions
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Pseudorabies Virus Vaccine Production by Application (2021-2032)
8.3.2 World Pseudorabies Virus Vaccine Production Value by Application (2021-2032)
8.3.3 World Pseudorabies Virus Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 MSD Animal Health
9.1.1 MSD Animal Health Details
9.1.2 MSD Animal Health Major Business
9.1.3 MSD Animal Health Pseudorabies Virus Vaccine Product and Services
9.1.4 MSD Animal Health Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 MSD Animal Health Recent Developments/Updates
9.1.6 MSD Animal Health Competitive Strengths & Weaknesses
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Details
9.2.2 Boehringer Ingelheim Major Business
9.2.3 Boehringer Ingelheim Pseudorabies Virus Vaccine Product and Services
9.2.4 Boehringer Ingelheim Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boehringer Ingelheim Recent Developments/Updates
9.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
9.3 HIPRA
9.3.1 HIPRA Details
9.3.2 HIPRA Major Business
9.3.3 HIPRA Pseudorabies Virus Vaccine Product and Services
9.3.4 HIPRA Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 HIPRA Recent Developments/Updates
9.3.6 HIPRA Competitive Strengths & Weaknesses
9.4 Ceva Sant? Animale
9.4.1 Ceva Sant? Animale Details
9.4.2 Ceva Sant? Animale Major Business
9.4.3 Ceva Sant? Animale Pseudorabies Virus Vaccine Product and Services
9.4.4 Ceva Sant? Animale Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Ceva Sant? Animale Recent Developments/Updates
9.4.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
9.5 Wuhan Keqian Biology
9.5.1 Wuhan Keqian Biology Details
9.5.2 Wuhan Keqian Biology Major Business
9.5.3 Wuhan Keqian Biology Pseudorabies Virus Vaccine Product and Services
9.5.4 Wuhan Keqian Biology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Wuhan Keqian Biology Recent Developments/Updates
9.5.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
9.6 Pulike Biological Engineering
9.6.1 Pulike Biological Engineering Details
9.6.2 Pulike Biological Engineering Major Business
9.6.3 Pulike Biological Engineering Pseudorabies Virus Vaccine Product and Services
9.6.4 Pulike Biological Engineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Pulike Biological Engineering Recent Developments/Updates
9.6.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
9.7 China Animal Husbandry Industry
9.7.1 China Animal Husbandry Industry Details
9.7.2 China Animal Husbandry Industry Major Business
9.7.3 China Animal Husbandry Industry Pseudorabies Virus Vaccine Product and Services
9.7.4 China Animal Husbandry Industry Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 China Animal Husbandry Industry Recent Developments/Updates
9.7.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
9.8 Jinyu Bio-Technology
9.8.1 Jinyu Bio-Technology Details
9.8.2 Jinyu Bio-Technology Major Business
9.8.3 Jinyu Bio-Technology Pseudorabies Virus Vaccine Product and Services
9.8.4 Jinyu Bio-Technology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Jinyu Bio-Technology Recent Developments/Updates
9.8.6 Jinyu Bio-Technology Competitive Strengths & Weaknesses
9.9 Guangdong Winsun Bio-Pharmaceutical
9.9.1 Guangdong Winsun Bio-Pharmaceutical Details
9.9.2 Guangdong Winsun Bio-Pharmaceutical Major Business
9.9.3 Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Product and Services
9.9.4 Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
9.9.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
9.10 Huapai Biopharm
9.10.1 Huapai Biopharm Details
9.10.2 Huapai Biopharm Major Business
9.10.3 Huapai Biopharm Pseudorabies Virus Vaccine Product and Services
9.10.4 Huapai Biopharm Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Huapai Biopharm Recent Developments/Updates
9.10.6 Huapai Biopharm Competitive Strengths & Weaknesses
9.11 Jilin Zhengye Biological Products
9.11.1 Jilin Zhengye Biological Products Details
9.11.2 Jilin Zhengye Biological Products Major Business
9.11.3 Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Product and Services
9.11.4 Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Jilin Zhengye Biological Products Recent Developments/Updates
9.11.6 Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
9.12 Sinopharm Yangzhou VAC Biological Engineering
9.12.1 Sinopharm Yangzhou VAC Biological Engineering Details
9.12.2 Sinopharm Yangzhou VAC Biological Engineering Major Business
9.12.3 Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Product and Services
9.12.4 Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
9.12.6 Sinopharm Yangzhou VAC Biological Engineering Competitive Strengths & Weaknesses
9.13 Sinovet Animal Health
9.13.1 Sinovet Animal Health Details
9.13.2 Sinovet Animal Health Major Business
9.13.3 Sinovet Animal Health Pseudorabies Virus Vaccine Product and Services
9.13.4 Sinovet Animal Health Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Sinovet Animal Health Recent Developments/Updates
9.13.6 Sinovet Animal Health Competitive Strengths & Weaknesses
9.14 Jofunhwa Group
9.14.1 Jofunhwa Group Details
9.14.2 Jofunhwa Group Major Business
9.14.3 Jofunhwa Group Pseudorabies Virus Vaccine Product and Services
9.14.4 Jofunhwa Group Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Jofunhwa Group Recent Developments/Updates
9.14.6 Jofunhwa Group Competitive Strengths & Weaknesses
9.15 Harbin Weike Biotechnology
9.15.1 Harbin Weike Biotechnology Details
9.15.2 Harbin Weike Biotechnology Major Business
9.15.3 Harbin Weike Biotechnology Pseudorabies Virus Vaccine Product and Services
9.15.4 Harbin Weike Biotechnology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Harbin Weike Biotechnology Recent Developments/Updates
9.15.6 Harbin Weike Biotechnology Competitive Strengths & Weaknesses
9.16 Qilu Animal Health Products
9.16.1 Qilu Animal Health Products Details
9.16.2 Qilu Animal Health Products Major Business
9.16.3 Qilu Animal Health Products Pseudorabies Virus Vaccine Product and Services
9.16.4 Qilu Animal Health Products Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Qilu Animal Health Products Recent Developments/Updates
9.16.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
9.17 Harbin Pharmaceutical Group Bio-vaccine
9.17.1 Harbin Pharmaceutical Group Bio-vaccine Details
9.17.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
9.17.3 Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Product and Services
9.17.4 Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
9.17.6 Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
9.18 Qingdao Yebio Bioengineering
9.18.1 Qingdao Yebio Bioengineering Details
9.18.2 Qingdao Yebio Bioengineering Major Business
9.18.3 Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Product and Services
9.18.4 Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Qingdao Yebio Bioengineering Recent Developments/Updates
9.18.6 Qingdao Yebio Bioengineering Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pseudorabies Virus Vaccine Industry Chain
10.2 Pseudorabies Virus Vaccine Upstream Analysis
10.2.1 Pseudorabies Virus Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Pseudorabies Virus Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Pseudorabies Virus Vaccine Production Mode
10.6 Pseudorabies Virus Vaccine Procurement Model
10.7 Pseudorabies Virus Vaccine Industry Sales Model and Sales Channels
10.7.1 Pseudorabies Virus Vaccine Sales Model
10.7.2 Pseudorabies Virus Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Pseudorabies Virus Vaccine Introduction
1.2 World Pseudorabies Virus Vaccine Supply & Forecast
1.2.1 World Pseudorabies Virus Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Pseudorabies Virus Vaccine Production (2021-2032)
1.2.3 World Pseudorabies Virus Vaccine Pricing Trends (2021-2032)
1.3 World Pseudorabies Virus Vaccine Production by Region (Based on Production Site)
1.3.1 World Pseudorabies Virus Vaccine Production Value by Region (2021-2032)
1.3.2 World Pseudorabies Virus Vaccine Production by Region (2021-2032)
1.3.3 World Pseudorabies Virus Vaccine Average Price by Region (2021-2032)
1.3.4 North America Pseudorabies Virus Vaccine Production (2021-2032)
1.3.5 Europe Pseudorabies Virus Vaccine Production (2021-2032)
1.3.6 China Pseudorabies Virus Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pseudorabies Virus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pseudorabies Virus Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Pseudorabies Virus Vaccine Demand (2021-2032)
2.2 World Pseudorabies Virus Vaccine Consumption by Region
2.2.1 World Pseudorabies Virus Vaccine Consumption by Region (2021-2026)
2.2.2 World Pseudorabies Virus Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Pseudorabies Virus Vaccine Consumption (2021-2032)
2.4 China Pseudorabies Virus Vaccine Consumption (2021-2032)
2.5 Europe Pseudorabies Virus Vaccine Consumption (2021-2032)
2.6 Japan Pseudorabies Virus Vaccine Consumption (2021-2032)
2.7 South Korea Pseudorabies Virus Vaccine Consumption (2021-2032)
2.8 ASEAN Pseudorabies Virus Vaccine Consumption (2021-2032)
2.9 India Pseudorabies Virus Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pseudorabies Virus Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Pseudorabies Virus Vaccine Production by Manufacturer (2021-2026)
3.3 World Pseudorabies Virus Vaccine Average Price by Manufacturer (2021-2026)
3.4 Pseudorabies Virus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pseudorabies Virus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pseudorabies Virus Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Pseudorabies Virus Vaccine in 2025
3.6 Pseudorabies Virus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pseudorabies Virus Vaccine Market: Region Footprint
3.6.2 Pseudorabies Virus Vaccine Market: Company Product Type Footprint
3.6.3 Pseudorabies Virus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pseudorabies Virus Vaccine Production Value Comparison
4.1.1 United States VS China: Pseudorabies Virus Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pseudorabies Virus Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pseudorabies Virus Vaccine Production Comparison
4.2.1 United States VS China: Pseudorabies Virus Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pseudorabies Virus Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pseudorabies Virus Vaccine Consumption Comparison
4.3.1 United States VS China: Pseudorabies Virus Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pseudorabies Virus Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pseudorabies Virus Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
4.5 China Based Pseudorabies Virus Vaccine Manufacturers and Market Share
4.5.1 China Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
4.6 Rest of World Based Pseudorabies Virus Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pseudorabies Virus Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Live Attenuated Vaccine
5.2.2 Inactivated Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pseudorabies Virus Vaccine Production by Type (2021-2032)
5.3.2 World Pseudorabies Virus Vaccine Production Value by Type (2021-2032)
5.3.3 World Pseudorabies Virus Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY STRAIN PLATFORM
6.1 World Pseudorabies Virus Vaccine Market Size Overview by Strain Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Strain Platform
6.2.1 Bartha-K61 Strain
6.2.2 HB98 Strain
6.2.3 C Strain
6.2.4 Other
6.3 Market Segment by Strain Platform
6.3.1 World Pseudorabies Virus Vaccine Production by Strain Platform (2021-2032)
6.3.2 World Pseudorabies Virus Vaccine Production Value by Strain Platform (2021-2032)
6.3.3 World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Pseudorabies Virus Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Pseudorabies Virus Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pseudorabies Virus Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Swine Farming Groups
8.2.2 Breeding Farms
8.2.3 Animal Disease Control Institutions
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Pseudorabies Virus Vaccine Production by Application (2021-2032)
8.3.2 World Pseudorabies Virus Vaccine Production Value by Application (2021-2032)
8.3.3 World Pseudorabies Virus Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 MSD Animal Health
9.1.1 MSD Animal Health Details
9.1.2 MSD Animal Health Major Business
9.1.3 MSD Animal Health Pseudorabies Virus Vaccine Product and Services
9.1.4 MSD Animal Health Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 MSD Animal Health Recent Developments/Updates
9.1.6 MSD Animal Health Competitive Strengths & Weaknesses
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Details
9.2.2 Boehringer Ingelheim Major Business
9.2.3 Boehringer Ingelheim Pseudorabies Virus Vaccine Product and Services
9.2.4 Boehringer Ingelheim Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boehringer Ingelheim Recent Developments/Updates
9.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
9.3 HIPRA
9.3.1 HIPRA Details
9.3.2 HIPRA Major Business
9.3.3 HIPRA Pseudorabies Virus Vaccine Product and Services
9.3.4 HIPRA Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 HIPRA Recent Developments/Updates
9.3.6 HIPRA Competitive Strengths & Weaknesses
9.4 Ceva Sant? Animale
9.4.1 Ceva Sant? Animale Details
9.4.2 Ceva Sant? Animale Major Business
9.4.3 Ceva Sant? Animale Pseudorabies Virus Vaccine Product and Services
9.4.4 Ceva Sant? Animale Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Ceva Sant? Animale Recent Developments/Updates
9.4.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
9.5 Wuhan Keqian Biology
9.5.1 Wuhan Keqian Biology Details
9.5.2 Wuhan Keqian Biology Major Business
9.5.3 Wuhan Keqian Biology Pseudorabies Virus Vaccine Product and Services
9.5.4 Wuhan Keqian Biology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Wuhan Keqian Biology Recent Developments/Updates
9.5.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
9.6 Pulike Biological Engineering
9.6.1 Pulike Biological Engineering Details
9.6.2 Pulike Biological Engineering Major Business
9.6.3 Pulike Biological Engineering Pseudorabies Virus Vaccine Product and Services
9.6.4 Pulike Biological Engineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Pulike Biological Engineering Recent Developments/Updates
9.6.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
9.7 China Animal Husbandry Industry
9.7.1 China Animal Husbandry Industry Details
9.7.2 China Animal Husbandry Industry Major Business
9.7.3 China Animal Husbandry Industry Pseudorabies Virus Vaccine Product and Services
9.7.4 China Animal Husbandry Industry Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 China Animal Husbandry Industry Recent Developments/Updates
9.7.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
9.8 Jinyu Bio-Technology
9.8.1 Jinyu Bio-Technology Details
9.8.2 Jinyu Bio-Technology Major Business
9.8.3 Jinyu Bio-Technology Pseudorabies Virus Vaccine Product and Services
9.8.4 Jinyu Bio-Technology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Jinyu Bio-Technology Recent Developments/Updates
9.8.6 Jinyu Bio-Technology Competitive Strengths & Weaknesses
9.9 Guangdong Winsun Bio-Pharmaceutical
9.9.1 Guangdong Winsun Bio-Pharmaceutical Details
9.9.2 Guangdong Winsun Bio-Pharmaceutical Major Business
9.9.3 Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Product and Services
9.9.4 Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
9.9.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
9.10 Huapai Biopharm
9.10.1 Huapai Biopharm Details
9.10.2 Huapai Biopharm Major Business
9.10.3 Huapai Biopharm Pseudorabies Virus Vaccine Product and Services
9.10.4 Huapai Biopharm Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Huapai Biopharm Recent Developments/Updates
9.10.6 Huapai Biopharm Competitive Strengths & Weaknesses
9.11 Jilin Zhengye Biological Products
9.11.1 Jilin Zhengye Biological Products Details
9.11.2 Jilin Zhengye Biological Products Major Business
9.11.3 Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Product and Services
9.11.4 Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Jilin Zhengye Biological Products Recent Developments/Updates
9.11.6 Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
9.12 Sinopharm Yangzhou VAC Biological Engineering
9.12.1 Sinopharm Yangzhou VAC Biological Engineering Details
9.12.2 Sinopharm Yangzhou VAC Biological Engineering Major Business
9.12.3 Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Product and Services
9.12.4 Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
9.12.6 Sinopharm Yangzhou VAC Biological Engineering Competitive Strengths & Weaknesses
9.13 Sinovet Animal Health
9.13.1 Sinovet Animal Health Details
9.13.2 Sinovet Animal Health Major Business
9.13.3 Sinovet Animal Health Pseudorabies Virus Vaccine Product and Services
9.13.4 Sinovet Animal Health Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Sinovet Animal Health Recent Developments/Updates
9.13.6 Sinovet Animal Health Competitive Strengths & Weaknesses
9.14 Jofunhwa Group
9.14.1 Jofunhwa Group Details
9.14.2 Jofunhwa Group Major Business
9.14.3 Jofunhwa Group Pseudorabies Virus Vaccine Product and Services
9.14.4 Jofunhwa Group Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Jofunhwa Group Recent Developments/Updates
9.14.6 Jofunhwa Group Competitive Strengths & Weaknesses
9.15 Harbin Weike Biotechnology
9.15.1 Harbin Weike Biotechnology Details
9.15.2 Harbin Weike Biotechnology Major Business
9.15.3 Harbin Weike Biotechnology Pseudorabies Virus Vaccine Product and Services
9.15.4 Harbin Weike Biotechnology Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Harbin Weike Biotechnology Recent Developments/Updates
9.15.6 Harbin Weike Biotechnology Competitive Strengths & Weaknesses
9.16 Qilu Animal Health Products
9.16.1 Qilu Animal Health Products Details
9.16.2 Qilu Animal Health Products Major Business
9.16.3 Qilu Animal Health Products Pseudorabies Virus Vaccine Product and Services
9.16.4 Qilu Animal Health Products Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Qilu Animal Health Products Recent Developments/Updates
9.16.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
9.17 Harbin Pharmaceutical Group Bio-vaccine
9.17.1 Harbin Pharmaceutical Group Bio-vaccine Details
9.17.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
9.17.3 Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Product and Services
9.17.4 Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
9.17.6 Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
9.18 Qingdao Yebio Bioengineering
9.18.1 Qingdao Yebio Bioengineering Details
9.18.2 Qingdao Yebio Bioengineering Major Business
9.18.3 Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Product and Services
9.18.4 Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Qingdao Yebio Bioengineering Recent Developments/Updates
9.18.6 Qingdao Yebio Bioengineering Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pseudorabies Virus Vaccine Industry Chain
10.2 Pseudorabies Virus Vaccine Upstream Analysis
10.2.1 Pseudorabies Virus Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Pseudorabies Virus Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Pseudorabies Virus Vaccine Production Mode
10.6 Pseudorabies Virus Vaccine Procurement Model
10.7 Pseudorabies Virus Vaccine Industry Sales Model and Sales Channels
10.7.1 Pseudorabies Virus Vaccine Sales Model
10.7.2 Pseudorabies Virus Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Pseudorabies Virus Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pseudorabies Virus Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pseudorabies Virus Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Pseudorabies Virus Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Pseudorabies Virus Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Pseudorabies Virus Vaccine Production Market Share by Region (2021-2026)
Table 9. World Pseudorabies Virus Vaccine Production Market Share by Region (2027-2032)
Table 10. World Pseudorabies Virus Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Pseudorabies Virus Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Pseudorabies Virus Vaccine Major Market Trends
Table 13. World Pseudorabies Virus Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Pseudorabies Virus Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Pseudorabies Virus Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Pseudorabies Virus Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pseudorabies Virus Vaccine Producers in 2025
Table 18. World Pseudorabies Virus Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Pseudorabies Virus Vaccine Producers in 2025
Table 20. World Pseudorabies Virus Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Pseudorabies Virus Vaccine Company Evaluation Quadrant
Table 22. World Pseudorabies Virus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pseudorabies Virus Vaccine Production Site of Key Manufacturer
Table 24. Pseudorabies Virus Vaccine Market: Company Product Type Footprint
Table 25. Pseudorabies Virus Vaccine Market: Company Product Application Footprint
Table 26. Pseudorabies Virus Vaccine Competitive Factors
Table 27. Pseudorabies Virus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pseudorabies Virus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pseudorabies Virus Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pseudorabies Virus Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Pseudorabies Virus Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 37. China Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pseudorabies Virus Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 47. World Pseudorabies Virus Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pseudorabies Virus Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Pseudorabies Virus Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Pseudorabies Virus Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pseudorabies Virus Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pseudorabies Virus Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Pseudorabies Virus Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Pseudorabies Virus Vaccine Production Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Table 55. World Pseudorabies Virus Vaccine Production by Strain Platform (2021-2026) & (K Dose)
Table 56. World Pseudorabies Virus Vaccine Production by Strain Platform (2027-2032) & (K Dose)
Table 57. World Pseudorabies Virus Vaccine Production Value by Strain Platform (2021-2026) & (USD Million)
Table 58. World Pseudorabies Virus Vaccine Production Value by Strain Platform (2027-2032) & (USD Million)
Table 59. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2026) & (US$/Dose)
Table 60. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2027-2032) & (US$/Dose)
Table 61. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Pseudorabies Virus Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Pseudorabies Virus Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Pseudorabies Virus Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Pseudorabies Virus Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Pseudorabies Virus Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Pseudorabies Virus Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Pseudorabies Virus Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Pseudorabies Virus Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Pseudorabies Virus Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 76. MSD Animal Health Major Business
Table 77. MSD Animal Health Pseudorabies Virus Vaccine Product and Services
Table 78. MSD Animal Health Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. MSD Animal Health Recent Developments/Updates
Table 80. MSD Animal Health Competitive Strengths & Weaknesses
Table 81. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 82. Boehringer Ingelheim Major Business
Table 83. Boehringer Ingelheim Pseudorabies Virus Vaccine Product and Services
Table 84. Boehringer Ingelheim Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boehringer Ingelheim Recent Developments/Updates
Table 86. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 87. HIPRA Basic Information, Manufacturing Base and Competitors
Table 88. HIPRA Major Business
Table 89. HIPRA Pseudorabies Virus Vaccine Product and Services
Table 90. HIPRA Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. HIPRA Recent Developments/Updates
Table 92. HIPRA Competitive Strengths & Weaknesses
Table 93. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 94. Ceva Sant? Animale Major Business
Table 95. Ceva Sant? Animale Pseudorabies Virus Vaccine Product and Services
Table 96. Ceva Sant? Animale Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Ceva Sant? Animale Recent Developments/Updates
Table 98. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 99. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 100. Wuhan Keqian Biology Major Business
Table 101. Wuhan Keqian Biology Pseudorabies Virus Vaccine Product and Services
Table 102. Wuhan Keqian Biology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Wuhan Keqian Biology Recent Developments/Updates
Table 104. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 105. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 106. Pulike Biological Engineering Major Business
Table 107. Pulike Biological Engineering Pseudorabies Virus Vaccine Product and Services
Table 108. Pulike Biological Engineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Pulike Biological Engineering Recent Developments/Updates
Table 110. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 111. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 112. China Animal Husbandry Industry Major Business
Table 113. China Animal Husbandry Industry Pseudorabies Virus Vaccine Product and Services
Table 114. China Animal Husbandry Industry Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. China Animal Husbandry Industry Recent Developments/Updates
Table 116. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 117. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 118. Jinyu Bio-Technology Major Business
Table 119. Jinyu Bio-Technology Pseudorabies Virus Vaccine Product and Services
Table 120. Jinyu Bio-Technology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Jinyu Bio-Technology Recent Developments/Updates
Table 122. Jinyu Bio-Technology Competitive Strengths & Weaknesses
Table 123. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 125. Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Product and Services
Table 126. Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 128. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Huapai Biopharm Basic Information, Manufacturing Base and Competitors
Table 130. Huapai Biopharm Major Business
Table 131. Huapai Biopharm Pseudorabies Virus Vaccine Product and Services
Table 132. Huapai Biopharm Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Huapai Biopharm Recent Developments/Updates
Table 134. Huapai Biopharm Competitive Strengths & Weaknesses
Table 135. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 136. Jilin Zhengye Biological Products Major Business
Table 137. Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Product and Services
Table 138. Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Jilin Zhengye Biological Products Recent Developments/Updates
Table 140. Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
Table 141. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 142. Sinopharm Yangzhou VAC Biological Engineering Major Business
Table 143. Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Product and Services
Table 144. Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
Table 146. Sinopharm Yangzhou VAC Biological Engineering Competitive Strengths & Weaknesses
Table 147. Sinovet Animal Health Basic Information, Manufacturing Base and Competitors
Table 148. Sinovet Animal Health Major Business
Table 149. Sinovet Animal Health Pseudorabies Virus Vaccine Product and Services
Table 150. Sinovet Animal Health Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Sinovet Animal Health Recent Developments/Updates
Table 152. Sinovet Animal Health Competitive Strengths & Weaknesses
Table 153. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 154. Jofunhwa Group Major Business
Table 155. Jofunhwa Group Pseudorabies Virus Vaccine Product and Services
Table 156. Jofunhwa Group Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Jofunhwa Group Recent Developments/Updates
Table 158. Jofunhwa Group Competitive Strengths & Weaknesses
Table 159. Harbin Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Harbin Weike Biotechnology Major Business
Table 161. Harbin Weike Biotechnology Pseudorabies Virus Vaccine Product and Services
Table 162. Harbin Weike Biotechnology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Harbin Weike Biotechnology Recent Developments/Updates
Table 164. Harbin Weike Biotechnology Competitive Strengths & Weaknesses
Table 165. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 166. Qilu Animal Health Products Major Business
Table 167. Qilu Animal Health Products Pseudorabies Virus Vaccine Product and Services
Table 168. Qilu Animal Health Products Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Qilu Animal Health Products Recent Developments/Updates
Table 170. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 171. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 172. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 173. Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Product and Services
Table 174. Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 176. Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
Table 177. Qingdao Yebio Bioengineering Basic Information, Manufacturing Base and Competitors
Table 178. Qingdao Yebio Bioengineering Major Business
Table 179. Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Product and Services
Table 180. Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Qingdao Yebio Bioengineering Recent Developments/Updates
Table 182. Qingdao Yebio Bioengineering Competitive Strengths & Weaknesses
Table 183. Global Key Players of Pseudorabies Virus Vaccine Upstream (Raw Materials)
Table 184. Global Pseudorabies Virus Vaccine Typical Customers
Table 185. Pseudorabies Virus Vaccine Typical Distributors
Table 1. World Pseudorabies Virus Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pseudorabies Virus Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pseudorabies Virus Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Pseudorabies Virus Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Pseudorabies Virus Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Pseudorabies Virus Vaccine Production Market Share by Region (2021-2026)
Table 9. World Pseudorabies Virus Vaccine Production Market Share by Region (2027-2032)
Table 10. World Pseudorabies Virus Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Pseudorabies Virus Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Pseudorabies Virus Vaccine Major Market Trends
Table 13. World Pseudorabies Virus Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Pseudorabies Virus Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Pseudorabies Virus Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Pseudorabies Virus Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pseudorabies Virus Vaccine Producers in 2025
Table 18. World Pseudorabies Virus Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Pseudorabies Virus Vaccine Producers in 2025
Table 20. World Pseudorabies Virus Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Pseudorabies Virus Vaccine Company Evaluation Quadrant
Table 22. World Pseudorabies Virus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pseudorabies Virus Vaccine Production Site of Key Manufacturer
Table 24. Pseudorabies Virus Vaccine Market: Company Product Type Footprint
Table 25. Pseudorabies Virus Vaccine Market: Company Product Application Footprint
Table 26. Pseudorabies Virus Vaccine Competitive Factors
Table 27. Pseudorabies Virus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pseudorabies Virus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pseudorabies Virus Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pseudorabies Virus Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Pseudorabies Virus Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pseudorabies Virus Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 37. China Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pseudorabies Virus Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Pseudorabies Virus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Market Share (2021-2026)
Table 47. World Pseudorabies Virus Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pseudorabies Virus Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Pseudorabies Virus Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Pseudorabies Virus Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pseudorabies Virus Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pseudorabies Virus Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Pseudorabies Virus Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Pseudorabies Virus Vaccine Production Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Table 55. World Pseudorabies Virus Vaccine Production by Strain Platform (2021-2026) & (K Dose)
Table 56. World Pseudorabies Virus Vaccine Production by Strain Platform (2027-2032) & (K Dose)
Table 57. World Pseudorabies Virus Vaccine Production Value by Strain Platform (2021-2026) & (USD Million)
Table 58. World Pseudorabies Virus Vaccine Production Value by Strain Platform (2027-2032) & (USD Million)
Table 59. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2026) & (US$/Dose)
Table 60. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2027-2032) & (US$/Dose)
Table 61. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Pseudorabies Virus Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Pseudorabies Virus Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Pseudorabies Virus Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Pseudorabies Virus Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Pseudorabies Virus Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Pseudorabies Virus Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Pseudorabies Virus Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Pseudorabies Virus Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Pseudorabies Virus Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 76. MSD Animal Health Major Business
Table 77. MSD Animal Health Pseudorabies Virus Vaccine Product and Services
Table 78. MSD Animal Health Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. MSD Animal Health Recent Developments/Updates
Table 80. MSD Animal Health Competitive Strengths & Weaknesses
Table 81. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 82. Boehringer Ingelheim Major Business
Table 83. Boehringer Ingelheim Pseudorabies Virus Vaccine Product and Services
Table 84. Boehringer Ingelheim Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boehringer Ingelheim Recent Developments/Updates
Table 86. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 87. HIPRA Basic Information, Manufacturing Base and Competitors
Table 88. HIPRA Major Business
Table 89. HIPRA Pseudorabies Virus Vaccine Product and Services
Table 90. HIPRA Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. HIPRA Recent Developments/Updates
Table 92. HIPRA Competitive Strengths & Weaknesses
Table 93. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 94. Ceva Sant? Animale Major Business
Table 95. Ceva Sant? Animale Pseudorabies Virus Vaccine Product and Services
Table 96. Ceva Sant? Animale Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Ceva Sant? Animale Recent Developments/Updates
Table 98. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 99. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 100. Wuhan Keqian Biology Major Business
Table 101. Wuhan Keqian Biology Pseudorabies Virus Vaccine Product and Services
Table 102. Wuhan Keqian Biology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Wuhan Keqian Biology Recent Developments/Updates
Table 104. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 105. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 106. Pulike Biological Engineering Major Business
Table 107. Pulike Biological Engineering Pseudorabies Virus Vaccine Product and Services
Table 108. Pulike Biological Engineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Pulike Biological Engineering Recent Developments/Updates
Table 110. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 111. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 112. China Animal Husbandry Industry Major Business
Table 113. China Animal Husbandry Industry Pseudorabies Virus Vaccine Product and Services
Table 114. China Animal Husbandry Industry Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. China Animal Husbandry Industry Recent Developments/Updates
Table 116. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 117. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 118. Jinyu Bio-Technology Major Business
Table 119. Jinyu Bio-Technology Pseudorabies Virus Vaccine Product and Services
Table 120. Jinyu Bio-Technology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Jinyu Bio-Technology Recent Developments/Updates
Table 122. Jinyu Bio-Technology Competitive Strengths & Weaknesses
Table 123. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 125. Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Product and Services
Table 126. Guangdong Winsun Bio-Pharmaceutical Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 128. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Huapai Biopharm Basic Information, Manufacturing Base and Competitors
Table 130. Huapai Biopharm Major Business
Table 131. Huapai Biopharm Pseudorabies Virus Vaccine Product and Services
Table 132. Huapai Biopharm Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Huapai Biopharm Recent Developments/Updates
Table 134. Huapai Biopharm Competitive Strengths & Weaknesses
Table 135. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 136. Jilin Zhengye Biological Products Major Business
Table 137. Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Product and Services
Table 138. Jilin Zhengye Biological Products Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Jilin Zhengye Biological Products Recent Developments/Updates
Table 140. Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
Table 141. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 142. Sinopharm Yangzhou VAC Biological Engineering Major Business
Table 143. Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Product and Services
Table 144. Sinopharm Yangzhou VAC Biological Engineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
Table 146. Sinopharm Yangzhou VAC Biological Engineering Competitive Strengths & Weaknesses
Table 147. Sinovet Animal Health Basic Information, Manufacturing Base and Competitors
Table 148. Sinovet Animal Health Major Business
Table 149. Sinovet Animal Health Pseudorabies Virus Vaccine Product and Services
Table 150. Sinovet Animal Health Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Sinovet Animal Health Recent Developments/Updates
Table 152. Sinovet Animal Health Competitive Strengths & Weaknesses
Table 153. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 154. Jofunhwa Group Major Business
Table 155. Jofunhwa Group Pseudorabies Virus Vaccine Product and Services
Table 156. Jofunhwa Group Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Jofunhwa Group Recent Developments/Updates
Table 158. Jofunhwa Group Competitive Strengths & Weaknesses
Table 159. Harbin Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Harbin Weike Biotechnology Major Business
Table 161. Harbin Weike Biotechnology Pseudorabies Virus Vaccine Product and Services
Table 162. Harbin Weike Biotechnology Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Harbin Weike Biotechnology Recent Developments/Updates
Table 164. Harbin Weike Biotechnology Competitive Strengths & Weaknesses
Table 165. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 166. Qilu Animal Health Products Major Business
Table 167. Qilu Animal Health Products Pseudorabies Virus Vaccine Product and Services
Table 168. Qilu Animal Health Products Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Qilu Animal Health Products Recent Developments/Updates
Table 170. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 171. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 172. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 173. Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Product and Services
Table 174. Harbin Pharmaceutical Group Bio-vaccine Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 176. Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
Table 177. Qingdao Yebio Bioengineering Basic Information, Manufacturing Base and Competitors
Table 178. Qingdao Yebio Bioengineering Major Business
Table 179. Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Product and Services
Table 180. Qingdao Yebio Bioengineering Pseudorabies Virus Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Qingdao Yebio Bioengineering Recent Developments/Updates
Table 182. Qingdao Yebio Bioengineering Competitive Strengths & Weaknesses
Table 183. Global Key Players of Pseudorabies Virus Vaccine Upstream (Raw Materials)
Table 184. Global Pseudorabies Virus Vaccine Typical Customers
Table 185. Pseudorabies Virus Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Pseudorabies Virus Vaccine Picture
Figure 2. World Pseudorabies Virus Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pseudorabies Virus Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Pseudorabies Virus Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Pseudorabies Virus Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 11. Pseudorabies Virus Vaccine Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 14. World Pseudorabies Virus Vaccine Consumption Market Share by Region (2021-2032)
Figure 15. United States Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. China Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. Europe Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Japan Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. South Korea Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. ASEAN Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. India Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. Producer Shipments of Pseudorabies Virus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Pseudorabies Virus Vaccine Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Pseudorabies Virus Vaccine Markets in 2025
Figure 25. United States VS China: Pseudorabies Virus Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Pseudorabies Virus Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Pseudorabies Virus Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 29. China Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 31. World Pseudorabies Virus Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Pseudorabies Virus Vaccine Production Value Market Share by Type in 2025
Figure 33. Live Attenuated Vaccine
Figure 34. Inactivated Vaccine
Figure 35. Others
Figure 36. World Pseudorabies Virus Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Pseudorabies Virus Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Pseudorabies Virus Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Pseudorabies Virus Vaccine Production Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Figure 40. World Pseudorabies Virus Vaccine Production Value Market Share by Strain Platform in 2025
Figure 41. Bartha-K61 Strain
Figure 42. HB98 Strain
Figure 43. C Strain
Figure 44. Other
Figure 45. World Pseudorabies Virus Vaccine Production Market Share by Strain Platform (2021-2032)
Figure 46. World Pseudorabies Virus Vaccine Production Value Market Share by Strain Platform (2021-2032)
Figure 47. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2032) & (US$/Dose)
Figure 48. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 49. World Pseudorabies Virus Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 50. Small Pack (Below 20 Doses per Vial)
Figure 51. Medium Pack (20–50 Doses per Vial)
Figure 52. Large Pack (Above 50 Doses per Vial)
Figure 53. World Pseudorabies Virus Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 54. World Pseudorabies Virus Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 55. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 56. World Pseudorabies Virus Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Pseudorabies Virus Vaccine Production Value Market Share by Application in 2025
Figure 58. Large-scale Swine Farming Groups
Figure 59. Breeding Farms
Figure 60. Animal Disease Control Institutions
Figure 61. Others
Figure 62. World Pseudorabies Virus Vaccine Production Market Share by Application (2021-2032)
Figure 63. World Pseudorabies Virus Vaccine Production Value Market Share by Application (2021-2032)
Figure 64. World Pseudorabies Virus Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 65. Pseudorabies Virus Vaccine Industry Chain
Figure 66. Pseudorabies Virus Vaccine Procurement Model
Figure 67. Pseudorabies Virus Vaccine Sales Model
Figure 68. Pseudorabies Virus Vaccine Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Pseudorabies Virus Vaccine Picture
Figure 2. World Pseudorabies Virus Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pseudorabies Virus Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Pseudorabies Virus Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Pseudorabies Virus Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Pseudorabies Virus Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Pseudorabies Virus Vaccine Production (2021-2032) & (K Dose)
Figure 11. Pseudorabies Virus Vaccine Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 14. World Pseudorabies Virus Vaccine Consumption Market Share by Region (2021-2032)
Figure 15. United States Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. China Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. Europe Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Japan Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. South Korea Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. ASEAN Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. India Pseudorabies Virus Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. Producer Shipments of Pseudorabies Virus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Pseudorabies Virus Vaccine Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Pseudorabies Virus Vaccine Markets in 2025
Figure 25. United States VS China: Pseudorabies Virus Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Pseudorabies Virus Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Pseudorabies Virus Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 29. China Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Pseudorabies Virus Vaccine Production Market Share 2025
Figure 31. World Pseudorabies Virus Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Pseudorabies Virus Vaccine Production Value Market Share by Type in 2025
Figure 33. Live Attenuated Vaccine
Figure 34. Inactivated Vaccine
Figure 35. Others
Figure 36. World Pseudorabies Virus Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Pseudorabies Virus Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Pseudorabies Virus Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Pseudorabies Virus Vaccine Production Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Figure 40. World Pseudorabies Virus Vaccine Production Value Market Share by Strain Platform in 2025
Figure 41. Bartha-K61 Strain
Figure 42. HB98 Strain
Figure 43. C Strain
Figure 44. Other
Figure 45. World Pseudorabies Virus Vaccine Production Market Share by Strain Platform (2021-2032)
Figure 46. World Pseudorabies Virus Vaccine Production Value Market Share by Strain Platform (2021-2032)
Figure 47. World Pseudorabies Virus Vaccine Average Price by Strain Platform (2021-2032) & (US$/Dose)
Figure 48. World Pseudorabies Virus Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 49. World Pseudorabies Virus Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 50. Small Pack (Below 20 Doses per Vial)
Figure 51. Medium Pack (20–50 Doses per Vial)
Figure 52. Large Pack (Above 50 Doses per Vial)
Figure 53. World Pseudorabies Virus Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 54. World Pseudorabies Virus Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 55. World Pseudorabies Virus Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 56. World Pseudorabies Virus Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Pseudorabies Virus Vaccine Production Value Market Share by Application in 2025
Figure 58. Large-scale Swine Farming Groups
Figure 59. Breeding Farms
Figure 60. Animal Disease Control Institutions
Figure 61. Others
Figure 62. World Pseudorabies Virus Vaccine Production Market Share by Application (2021-2032)
Figure 63. World Pseudorabies Virus Vaccine Production Value Market Share by Application (2021-2032)
Figure 64. World Pseudorabies Virus Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 65. Pseudorabies Virus Vaccine Industry Chain
Figure 66. Pseudorabies Virus Vaccine Procurement Model
Figure 67. Pseudorabies Virus Vaccine Sales Model
Figure 68. Pseudorabies Virus Vaccine Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
